Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Stomach Neoplasms 30Peritoneal Neoplasms 24Ovarian Neoplasms 24Fallopian Tube Neoplasms 13Carcinoma, Ovarian Epithelial 12Colorectal Neoplasms 11Neoplasm Metastasis 5Appendiceal Neoplasms 5Recurrence 3Pancreatic Neoplasms 3Neoplasms 3Uterine Neoplasms 2Sarcoma 2Pseudomyxoma Peritonei 2Mesothelioma 2Hyperthermic Intraperitoneal Chemotherapy 2Gastric Adenocarcinoma 2Desmoplastic Small Round Cell Tumor 2Colonic Neoplasms 2Carcinoma 2Wilms Tumor 1Uterine Cervical Neoplasms 1Stage â…¢ Gastric Cancer 1Rhabdomyosarcoma 1Rectal Neoplasms 1Peritoneal Metastases From Gastric Cancer 1Peritoneal Metastases From Colorectal Cancer 1Peritoneal Diseases 1Pelvic Neoplasms 1Ovarian Epithelial Cancer Recurrent 1

Interventions

tremelimumab 1durvalumab 1Sodium Chloride 1Radiotherapy 1Lidocaine 1Hyperthermic Intraperitoneal Chemotherapy 1Cystectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Invasive Bladder Cancer × Hyperthermic Intraperitoneal Chemotherapy × Clear all
NCT03514888 2023-08-28

HIPEC After Radical Cystectomy for High Risk Bladder Cancer

Weill Medical College of Cornell University

Phase NA Completed
7 enrolled
Genitourinary

Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡